Skip to main content
. 2017 Jul 27;8(56):95116–95134. doi: 10.18632/oncotarget.19618

Figure 9. Abemaciclib in combination with sunitinib is active in RCC in mice.

Figure 9

Mice with xenograft RCC tumors were first treated with sunitinib or vehicle. At the end of treatment, all mice were treated with combination abemaciclib/sunitinib. (A) Tumor size in individual mice. (B) Mean tumor size in each treatment cohort. Error bars represent standard deviation. The trend lines are shown within each group.